Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
EU General Court rejects lactic acid supplement TM
Europe
The EU’s General Court has upheld the European Union Intellectual Property Office’s finding that a trademark for dietary supplements was descriptive of the relevant services to an Italian speaking public.   6 June 2019
Eli Lilly licenses AI tech for preclinical development
Americas
San Francisco-based biotech company Atomwise could be set to receive up to $1 million per target in milestone payments following a partnership agreement with Eli Lilly.   6 June 2019
German court deals blow to Sanofi over cholesterol drug
Big Pharma
A German court has rejected a bid from French pharmaceutical company Sanofi to have a patent infringement case dismissed.   5 June 2019
Genetics
Danish research company Bioneer has secured a non-exclusive licence to CRISPR/Cas9 technology owned by French geneticist Emmanuelle Charpentier.   4 June 2019
Big Pharma
A Japanese court has dismissed a patent infringement lawsuit brought by Roche subsidiary Genentech against Sandoz, a division of Novartis.   4 June 2019
Big Pharma
The US Food and Drug Administration has sent a warning letter to a stem cell company for marketing a number of unapproved treatments for a variety of life-threatening conditions.   4 June 2019
Americas
American pharmaceutical company Eli Lilly has secured an exclusive licence for a non-opioid, non-addictive chronic pain treatment from Boston-based biotech company Centrexion Therapeutics.   3 June 2019
Americas
The University of California has settled a dispute over the use of a diagnostic tool in graduate research projects.   31 May 2019
Big Pharma
German pharmaceutical company Boehringer Ingelheim has entered into a second licence and collaboration agreement with Danish biotech company Gubra for the development of an obesity treatment.   30 May 2019
Americas
US biotechnology company Celgene has taken legal action against the registrant of a domain name which allegedly infringes Celgene’s trademarks.   30 May 2019